Anais Brasileiros de Dermatologia

ISSN: 0365-0596

Anais Brasileiros de Dermatologia is the official scientific publication of the Brazilian Society of Dermatology (SBD - Sociedade Brasileira de Dermatologia). The journal has been published since 1925.

It is a bimonthly open access peer-reviewed journal devoted to the dissemination of studies, evidence and technical-scientific reports that are original and unpublished, results from research, reviews or communications about dermatology and related fields.

The journal is focused on Tropical Dermatology, Parasitic and Infectious Dermatology, STDs/AIDS and Dermopathology.

The opinions and statements contained in the journal are the sole and exclusive responsibility of their authors, and do not necessarily coincide with those of the Editorial Staff, the Advisory Board or the Brazilian Society of Dermatology.

Indexed in:

PubMed/PMC/MEDLINE, Scopus, Web of Science, SciELO, Lilacs, Embase, and Latindex

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

2.6

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

2.4

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.429

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.897

View more metrics

Open Access Option

Journal Information

Articles in press

Articles in press are accepted, peer reviewed articles that are not yet assigned to volumes/issues, but are citable using DOI. More info

Should patients undergoing hematopoietic stem cell transplantation undergo screening and monitoring for skin cancer?

Miguel Mansilla-Polo

10.1016/j.abd.2024.06.007

Full text access

Available online 13 January 2025

Successful Omalizumab treatment in delayed pressure urticaria as confirmed by stimulation test

Cesare Ariasi, Gabriele Perazzolli, Luca Rubelli, Alessandro Fraghì, Piergiacomo Calzavara-Pinton

10.1016/j.abd.2024.06.008

Full text access

Available online 13 January 2025

Dapsone-induced methemoglobinemia in a child with leprosy

John Verrinder Veasey, Bruna Cavaleiro de Macedo Souza, Guilherme Camargo Julio Valinoto

10.1016/j.abd.2024.05.006

Full text access

Available online 10 January 2025

Risankizumab and guselkumab for psoriasis: a 1-year real-world practice indirect comparison

Leyla Baykal Selçuk, Hande Ermiş Akkuş, Burak Akşan, Deniz Aksu Arıca

10.1016/j.abd.2024.05.005

Full text access

Available online 10 January 2025

Superficial acral fibromyxoma with bone involvement: description and postoperative follow-up

Ana Carolina Baião Silva, Helena Maciel Guerra, Leonardo Ávila Ferreira, Rafael Fantelli Stelini, Laura Bertanha, Renata Ferreira Magalhães

10.1016/j.abd.2024.04.015

Full text access

Available online 10 January 2025

Telemedicine (mobile-Health) as an alternative in the follow-up of patients in a randomized clinical trial for the treatment of cutaneous leishmaniasis in the state of Amazonas, Brazil

Silmara Navarro Pennini, Jorge Augusto de Oliveira Guerra, Paula Frassinetti Bessa Rebello, Marília Rosa Abtibol-Bernardino, Amanda Canto Duarte, Higor Marques de Queiroz, Anette Chrusciak-Talhari, Maria das Graças Vale Barbosa Guerra, Sinésio Talhari

10.1016/j.abd.2024.08.003

Full text access

Available online 10 January 2025